论文部分内容阅读
目前我国肺癌发病率和病死率呈明显上升趋势,在各种恶性肿瘤中发病率排名第1,肺癌总的5年生存率仍在15%以下〔1〕。在肺癌治疗中,尤其在放化疗之后经常出现白细胞下降骨髓抑制。我科自2005-2012年出现肺癌并发骨髓抑制同时伴有血红蛋白减少20例,应用成分输血治疗疗效显著,现将临床治疗情况介绍如下。
At present, the incidence and mortality of lung cancer showed a clear upward trend in the incidence of various malignant tumors ranked No. 1, the overall 5-year lung cancer survival rate is still below 15% 〔1〕. In lung cancer treatment, especially after radiotherapy and chemotherapy often appear leukopenia bone marrow suppression. From 2005 to 2012, our department had myelosuppression complicated with myelosuppression accompanied by a decrease of hemoglobin in 20 cases. The application of component transfusion has a significant therapeutic effect. The clinical treatment is described as follows now.